0001209191-21-021816.txt : 20210318
0001209191-21-021816.hdr.sgml : 20210318
20210318171711
ACCESSION NUMBER: 0001209191-21-021816
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210316
FILED AS OF DATE: 20210318
DATE AS OF CHANGE: 20210318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SANDELL SCOTT D
CENTRAL INDEX KEY: 0001237289
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37939
FILM NUMBER: 21755416
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Marker Therapeutics, Inc.
CENTRAL INDEX KEY: 0001094038
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880277072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3200 SOUTHWEST FREEWAY
STREET 2: SUITE 2500
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: (713) 400-6400
MAIL ADDRESS:
STREET 1: 3200 SOUTHWEST FREEWAY
STREET 2: SUITE 2500
CITY: HOUSTON
STATE: TX
ZIP: 77027
FORMER COMPANY:
FORMER CONFORMED NAME: TAPIMMUNE INC.
DATE OF NAME CHANGE: 20170629
FORMER COMPANY:
FORMER CONFORMED NAME: TAPIMMUNE INC
DATE OF NAME CHANGE: 20070628
FORMER COMPANY:
FORMER CONFORMED NAME: GENEMAX CORP
DATE OF NAME CHANGE: 20020718
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-16
0
0001094038
Marker Therapeutics, Inc.
MRKR
0001237289
SANDELL SCOTT D
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM
MD
21093
0
0
1
0
Common Stock
2021-03-16
4
P
0
5714285
1.75
A
10714285
I
See Note 1
The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest.
/s/ Sasha Keough, attonrey-in-fact
2021-03-18